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ABSTRACT  
Background: Nephrotic syndrome is a kidney disease caused by damage to the cluster of small blood vessels in the kidney. Nephrotic 
syndrome causes misfunctioning of the kidney that affects metabolism of the body significantly. It causes complications of blood clots, high 
blood cholesterol and elevated blood triglycerides, poor nutrition, high blood pressure, acute kidney failure, chronic kidney disease and various 
infections. 
Objectives: The present investigation was objected to study prevalence rate, side effect of prescribed drugs and co-morbidity associated with 
current drug therapy in patient suffering with nephrotic syndrome. 
Methodologies: The present observational study was conducted on 43 nephrotic syndrome patients. These patients were evaluated for effects 
and side effects of prescribed drugs. Co-morbidity related to drug current prescribed was assessed and prescribed drugs for co-morbidity for 
also assessed. Prevalence rate of nephrotic syndrome was calculated among the all investigated patients. Patients were investigated who signed 
consent form. Patients above 18 years of age were excluded from study. 
Results: The involved 43 patients of nephrotic syndrome. These patients were prescribed with Corticosteroids (27%), Immunomodulator 
(8%), Immunosuppressant (5%), Diuretics (20%), ACE Inhibitors (5%), Angiotensin II receptor antagonist (5%). Co-morbidity were related to 
current drugs were observed and it was found that 9 (20%) patients were  suffering from asthma, 3 (7%) patients were suffering epilepsy, 1 
(2%) patients were suffering from inflammatory bowel disease, 5 (11%) patients were suffering from other diseases along with nephrotic 
syndrome. Prevalence rate of nephrotic syndrome was found 2.38% in patients.  
Conclusion: The present study revealed that the current prescribed drugs for nephrotic syndrome causes side effects that are skin infection, 
behavioral changes, blood in urine and decreased neutrophils. And co-morbidity of asthma, epilepsy, inflammatory bowel disease and other 
disease were present in patients of nephrotic syndrome. 1 patient out of every 42 investigated patients was suffering from  nephrotic 
syndrome. 
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INTRODUCTION: 
Nephrotic Syndrome is a rare disease found in pediatric 
patients. Nephrotic syndrome is a kidney disorder that 
results in misfunctioning of the nephrotic cells of the kidney. 
In nephrotic syndrome cluster of small blood vessels 
(glomeruli) in kidney are damaged. Nephrotic syndrome 
causes to excrete too much protein in urine and filtration 
process in kidney is severely affected. It is the second most 
frequent cause of chronic kidney disease in children. It is 
usually treated with corticosteroid drugs, but 15% of treated 
children do not respond to this type of drug. These causes 
may progress to chronic or end-stage kidney failure, 
requiring dialysis or transplantation.   
My main aim was to check prevalence rate and side effect of 
the drugs used in comorbidities. Data collection from the 
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tertiary hospital I analyzed that we need to check the 
prevalence rate and side effects of the drugs, so that the side 
effects can be reduced and better treatment for comorbid 
condition and also analyse drugs prescribed per perception. 
Nephrotic syndrome is a kidney disorder that causes your 
body to excrete too much protein in your urine. Nephrotic 
syndrome is an important chronic disease in children, 
characterized by minimal change disease in the majority. [1] 
Nephrotic syndrome is usually caused by damage to the 
clusters of small blood vessels in your kidneys that filter 
waste and excess water from your blood. Nephrotic 
syndrome causes swelling (edema), particularly in your feet 
and ankles, and increases the risk of other health problems.[1 
 
Fig 1: Cross section of kidney 
 Blood enters your kidneys through your renal arteries. Your 
kidneys remove excess fluid and waste material from your 
blood through units called nephrons. Each nephron contains 
a filter (glomerulus) that has a network of tiny blood vessels 
called capillaries. The glomeruli filter waste products and 
substances your body needs such as sodium, phosphorus and 
potassium which then pass through tiny tubules. The 
substances your body needs are reabsorbed into the blood. 
[2-3] 
Symptoms 
Signs and symptoms of nephrotic syndrome include: 
 Severe swelling (edema), particularly around your eyes 
and in your ankles and feet 
 Foamy urine, which may be caused by excess protein in 
your urine 
 Weight gain due to excess fluid retention 
 Fatigue 
 Loss of appetite[2] 
Causes 
Nephrotic syndrome is usually caused by damage to the 
clusters of tiny blood vessels (glomeruli) of your kidneys. 
The glomeruli filter your blood as it passes through your 
kidneys, separating things your body needs from those it 
doesn't. Healthy glomeruli keep blood protein (mainly 
albumin) which is needed to maintain the right amount of 
fluid in your body from seeping into your urine. When 
damaged, glomeruli allow too much blood protein to leave 
your body, leading to nephrotic syndrome.[2] 
Many Possible Causes 
Many diseases and conditions can cause glomerular damage 
and lead to nephrotic syndrome, including:[4,5,6,7] 
 Diabetic kidney disease. Diabetes can lead to kidney 
damage (diabetic nephropathy) that affects the 
glomeruli. 
 Minimal change disease. This is the most common 
cause of nephrotic syndrome in children. Minimal 
change disease results in abnormal kidney function, but 
when the kidney tissue is examined under a 
microscope, it appears normal or nearly normal. The 
cause of the abnormal function typically can't be 
determined. 
 Focal segmental glomerulosclerosis. Characterized 
by scattered scarring of some of the glomeruli, this 
condition may result from another disease or a genetic 
defect or occur for no known reason. 
 Membranous nephropathy. This kidney disorder is 
the result of thickening membranes within the 
glomeruli. The exact cause of the thickening isn't 
known, but it's sometimes associated with other 
medical conditions, such as hepatitis B, malaria, lupus 
and cancer. 
 Systemic lupus erythematosus. This chronic 
inflammatory disease can lead to serious kidney 
damage. 
 Amyloidosis. This disorder occurs when substances 
called amyloid proteins accumulate in your organs. 
Amyloid buildup often affects the kidneys, damaging 
their filtering system. 
 Blood clot in a kidney vein. Renal vein thrombosis, 
which occurs when a blood clot blocks a vein connected 
to the kidney, can cause nephrotic syndrome. 
Who is at a risk of nephrotic syndrome? 
Anyone can get nephrotic syndrome but it is slightly more 
common in men than in women. In children, it happens most 
often between the ages of 2 and 6.  it's usually first diagnosed 
in children aged between 2 and 5 years old. It affects more 
boys than girls. Around 1 in every 50,000 children are 
diagnosed with the condition each year. There are other 
factors that may increase your risk. [3-4] 
Treatment is directed at the underlying cause. Other efforts 
include managing high blood pressure, high blood 
cholesterol, and infection risk. A low salt diet and limiting 
fluids is often recommended. About 5 per 100,000 people are 
affected per year. The usual underlying cause varies between 
children and adults. [5] 
Types of Nephrotic Syndrome? 
Nephrotic syndrome has many causes and may either be the 
result of a glomerular disease that can be either limited to 
the kidney, called primary nephrotic syndrome 
(primary glomerulonephrosis), or a condition that affects the 
kidney and other parts of the body, called secondary 
nephrotic syndrome. [8-10] 
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CLASSIFICATION 
A broad classification of nephrotic syndrome based on underlying cause: 
 
 
 
 
 
 
Nephrotic syndrome is often classified histologically. 
 
 
 
 
 
 
 
Signs and Symptons 
Nephrotic syndrome is characterized by large amounts 
of proteinuria (>3.5 g per 1.73 m2 body surface area per 
day,[21] or > 40 mg per square meter body surface area per 
hour in children), hypoalbuminemia (< 2,5 g/dl), 
hyperlipidaemia, and edema that begins in the face. 
Lipiduria (lipids in urine) can also occur,but is not essential 
for the diagnosis of nephrotic syndrome. Hyponatremia also 
occurs with a low fractional sodium excretion. 
Complications 
Possible complications of nephrotic syndrome include:[9,10] 
 Blood clots. The inability of the glomeruli to filter 
blood properly can lead to loss of blood proteins that 
help prevent clotting. This increases your risk of 
developing a blood clot (thrombus) in your veins. 
 High blood cholesterol and elevated blood 
triglycerides. When the level of the protein albumin in 
your blood falls, your liver makes more albumin. At the 
same time, your liver releases more cholesterol and 
triglycerides. 
 Poor nutrition. Loss of too much blood protein can 
result in malnutrition. This can lead to weight loss, but 
it may be masked by swelling. You may also have too 
few red blood cells (anemia) and low levels of vitamin 
D and calcium. 
 High blood pressure. Damage to your glomeruli and 
the resulting buildup of wastes in your bloodstream 
(uremia) can raise your blood pressure. 
 Acute kidney failure. If your kidneys lose their ability 
to filter blood due to damage to the glomeruli, waste 
products may build up quickly in your blood. If this 
happens, you may need emergency dialysis an artificial 
means of removing extra fluids and waste from your 
blood typically with an artificial kidney machine 
(dialyzer). 
 Chronic kidney disease. Nephrotic syndrome may 
cause your kidneys to gradually lose their function 
over time. If kidney function falls low enough, you may 
require dialysis or a kidney transplant. 
 Infections. People with nephrotic syndrome have an 
increased risk of infections. 
Risk Factors 
Factors that can increase your risk of nephrotic syndrome 
include:[2-3] 
 Medical conditions that can damage your 
kidneys. Certain diseases and conditions increase your 
risk of developing nephrotic syndrome, such as 
diabetes, lupus, amyloidosis and other kidney diseases. 
 Certain medications. Examples of medications that 
can cause nephrotic syndrome include nonsteroidal 
anti-inflammatory drugs and drugs used to fight 
infections. 
 Certain infections. Examples of infections that 
increase the risk of nephrotic syndrome include HIV, 
hepatitis B, hepatitis C and malaria. 
Diagnosis of Nephrotic Syndrome 
Along with obtaining a complete medical history, a series 
of biochemical tests are required in order to arrive at an 
accurate diagnosis that verifies the presence of the illness. In 
addition, imaging of the kidneys (for structure and presence 
of two kidneys) is sometimes carried out, and/or a biopsy of 
the kidneys. The first test will be a urinalysis to test for high 
levels of proteins, as a healthy subject excretes an 
insignificant amount of protein in their urine.  
The tests are given below: 
 Urine test 
 Blood test 
 Removing a sample of kidney tissue for testing. 
Treatment of Nephrotic Syndrome 
Treatment for nephrotic syndrome involves treating any 
underlying medical condition that may be causing your 
nephrotic syndrome. 
NEPHROTIC SYNDROME 
PRIMARY 
NEPHROTIC SYNDROME 
MCD FSGS MGN MPGN 
SECONDARY 
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Medications may include:[11] 
 Blood pressure medications.[12] 
 Water pills.[13] 
 Cholesterol-reducing medications. [14] 
 Blood thinners. [15-16] 
 Immune system-suppressing medications. [17-19] 
What is Comorbidity? 
Comorbidity is a term you might hear pretty frequently in 
psychology as well as in medicine more broadly. It is 
important to understand comorbidity and how it works so 
that you can evaluate and help comorbid patients, or 
patients that are suffering from multiple, related diseases or 
disorders at the same time. In psychology, comorbidity 
refers to more than one disorders or diseases that exist 
alongside a primary diagnosis, which is the reason a patient 
gets referred and/or treated.[22] 
Prevalence:  
The proportion of individuals in a population having a 
disease or characteristic. Prevalence is a statistical concept 
referring to the number of cases of a disease that are present 
in a particular population at a given time, whereas incidence 
refers to the number of new cases that develop in a given 
period of time.[23] 
MATERIALS AND METHOD:  
The study was conducted in Tertiary Care Hospital, 
Dehradun. The Patients attending the Inpatient facilities of 
the department of Pediatric ward with clinical diagnosis of 
Nephrotic Syndrome were included in the study. This was 
present observational study which was conducted on 43 
nephrotic syndrome patients. These patients were evaluated 
for effects and side effects of prescribed drugs. Co-morbidity 
related to drug current prescribed was assessed and 
prescribed drugs for co-morbidity for also assessed. 
Prevalence rate of nephrotic syndrome was calculated 
among the all investigated patients. Patients were 
investigated who signed consent form. Patients above 18 
years of age were excluded from study.  
RESULTS:  
The study was conducted on 43 patients for prevalence rate, 
side effect and co-morbidities associated with nephrotic 
syndrome among inpatient of pediatric care unit at SHRI 
MAHANT INDIRESH HOSPITAL, DEHRADUN. All subjects 
satisfy the inclusion and exclusion criteria were included as 
the study population. The data which were collected, 
analyzed and evaluated to get the accurate results. 
 Gender categorization 
According to the data collected in study, among 43 patients 
36 were males and 07 were females accounting for 84% and 
14% respectively as shown in table 1 and figure 1. 
Table no 1 Gender distribution of the patient: 
Gender No. of patients Percentage % 
Male 36 84% 
Female 07 16% 
Total 43 100% 
 
 
Figure 1. Representing the gender distribution of the 
patients. 
 
Age group categorization 
Out of 43 patients 28 (65%) patients were in age group of 
01-06 years, 09 (21%) patients were in age group of 07-12 
years, 06 (14%) patients were in age group of 13-18 shown 
in table 2 and figure 2. 
Table 2. Age classification in different categories: 
Age No. of patients Percentage % 
01-06 28 65% 
07-12 09 21% 
13-18 06 14% 
 
 
Figure 2. Representing the age group classification. 
 
 Associated co-morbidities: 
According to this study out of 43 patients 09 (20%) patients 
have a history of asthma, 03 (7%) patients have a history of 
epilepsy, 02 (4%) patients have a combine history of asthma 
and epilepsy, 01 (2%) patient have a history of IBD and 02 
(4%) patients have a history of prematurity, 03 (7%) 
patients have other condition associated with nephrotic 
syndrome infraction as shown in table 3. and figure 3. 
 
 
Male 
84% 
Female 
16% 
01 to 
06 
65% 
07 to 
12 
21% 
13 to 
18 
14% 
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Table 3 Associated co-morbidities. 
Associated co-morbidities 
No. of  
Patients 
Percentage % 
None 27 60% 
Asthma 09 20% 
Epilepsy 03 7% 
Inflammatory Bowel 
Disease 
01 2% 
Prematurity 02 4% 
Others 03 7% 
 
 
Figure 3. Representing the Associated co-morbidities 
 Different categories of drugs prescribed in NS patients: 
According to this study, out of 43 patients, a total no. of 167 
drugs was prescribed among patients of nephrotic 
syndrome. The study showed that Corticosteroids have been 
prescribed in most of the patients, followed by 
Immunomodulator, Diuretics, Immunosuppressant, 
Methylxanthine, ACE Inhibitor, Angiotensin II receptor 
antagonist, Sedatives, ACTH Analogue, Aminosalicylates and 
miscellaneous drugs as shown in table 4 and figure 4. 
Table 4. Different categories of drugs prescribed in NS 
patients 
Drug class Frequency Percentage % 
Corticosteroids 43 27% 
Immunomodulator 13 08% 
Immunosuppressant 08 05% 
Diuretics 31 20% 
Angiotensin-converting 
Enzyme (ACE) 
Inhibitors 
07 05% 
Angiotensin II receptor 
antagonist 
07 05% 
*Methylxanthine 11 8% 
*Sedatives  04 2% 
*Aminosalicylates 02 1% 
Miscellaneous 28 18% 
*Drug used in co-morbidities
 
 
 
Figure 4. Representing different categories of drugs prescribed in NS patients 
Side effects associated with drug used in treatment of NS. 
According to study, out of 43 patients, a total no. of 7 patients was found to have skin infection and 4 patients had behavioural 
change, 4 patients was found to have problem of blood in urine and 3 patients had decrease in Neutrophils. 
Table 6 Side effects associated with drug used in treatment of NS. 
Side Effects No. of Patients Percentage (%) 
Skin Infection 7 16% 
Behavioral change 4 9% 
Blood in urine 4 9% 
Decreased neutrophils 3 7% 
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Figure 6. Side effect due to drug used in NS. 
Prevalence rate for NS. 
According to study, total no. of patient who is affected with 
nephrotic syndrome was 43. This study was conducted in 
pediatric unit of Shri Mahant Indresh Hospital were total no. 
of patient who is admitted in pediatric ward in 6 month 
period was 1811. Hence the prevalence rate for nephrotic 
syndrome in pediatric unit is 
                                  
Prevalence Rate =  
No. of patients in sample with characteristic 
━━━━━━━━━━━━━━━━━━  
                           Total no. of patients in sample 
                                       43 
Prevalence Rate = ━━━  
                                       1806 
                                          1 
Prevalence Rate = ━━━  
                                         42 
 
Figure 7. Prevalence rate for NS 
DISCUSSION: 
Nephrotic syndrome is a kidney disorder that results in 
misfunctioning of the nephrotic cells of the kidney. In 
nephrotic syndrome cluster of small blood vessels 
(glomeruli) in kidney are damaged. Nephrotic syndrome 
causes to excrete too much protein in urine and filtration 
process in kidney is severely affected. Nephrotic syndrome 
is an important chronic disease in children. Nephrotic 
syndrome is generally caused due to many metabolic 
disorders and diseases that are diabetes, hepatitis, minimal 
change disease, focal segmental glomerulosclerosis, 
membranous nephropathy, systemic lupus erythematosus 
and Amyloidosis. Nephrotic syndrome can cause serious 
complications including blood clots, high blood cholesterol 
and elevated blood triglycerides, poor nutrition, high blood 
pressure, acute kidney failure, chronic kidney disease and 
various infections. 
The present study was conducted to analyze patients of 
nephrotic syndrome and assess the most commonly 
prescribed drug for it. The rational uses of prescribed drugs 
were evaluated and patients were counseled about 
nephrotic syndrome and prescribed drugs. Total 43 
nephrotic syndrome cases were studied. Patients were 
suffering from severe swelling (edema), particularly around 
eyes and in ankles and feet, foamy urine caused by excess 
protein in urine, weight gain due to excess fluid retention, 
fatigue and loss of appetite. 
The medication prescribed for them were Prednisone, 
Prednisolone (Orapred, Pediapred, Prelone), Diuretics, 
Furosemide (Lasix), Metolazone (Zaroxolyn), Plasma 
protein, Albumin (Albuminar, Buminate, Flexbumin, 
Plasbumin), Immunosuppressive agents, Mycophenolate 
mofetil (CellCept, Myfortic), and Tacrolimus (Prograf). These 
prescribed drugs also showed side effects on the patients. 
After counselling and medical investigation, it was found 
that the most common side effects of prescribed drugs were 
skin infection, behavioral changes, blood in urine and 
decreased neutrophils.  
Co-morbidity related to nephrotic syndrome was also 
investigated in this study. It was found, along with nephrotic 
syndrome 9 (20%) patients were also suffering from asthma, 
3 (7%) patients were suffering epilepsy, 1 (2%) patients 
were suffering from inflammatory bowel disease, 5 (11%) 
patients were suffering from other diseases.  
In the co-morbid cases Methylxanthine was prescribed in 11 
(25%), Sedatives were prescribed in 4 (9%), Amino 
salicylates were prescribed in 02 (4%) patients followed by 
Miscellaneous Drug 28 (65%).  
In this study the prevalence rate of nephrotic syndrome was 
observed and it was found that 43 patients were found 
positive to nephrotic syndrome out of 1806 patients. 
Prevalence rate was 2.38% meaning that 1 out of every 42 
investigated patients was suffering from nephrotic 
syndrome.  
CONCLUSION: 
In the present study, patients of nephrotic syndrome were 
investigated to find causes of nephrotic syndrome and 
prescribed drugs for it. Rational of prescribed drugs was 
assessed and side effects of prescribed drugs were 
evaluated. Co-morbidity related to nephrotic syndrome in 
patients was also investigated with prescribed drug for co-
morbidity. The prevalence rate of the nephrotic syndrome 
was also observed. 
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Total 43 patients were found positive to nephrotic syndrome 
out of 1806 patients with prevalence rate of 2.38%. The 
nephrotic syndrome patients were prescribed for 
Prednisone, Prednisolone, Diuretics, Furosemide, 
Metolazone, Plasma protein, Albumin, Immunosuppressive 
agents, Mycophenolate mofetil, and Tacrolimus. These drugs 
were prescribed to reduce edema, removal of excess water 
and salts from body through kidney, immunosuppression 
and to increase oncotic pressure.  
Prescribed drugs showed side effects in patients, side effects 
were skin infection, behavioural changes, blood in urine and 
decreased neutrophils. These side effects were due the 
presence of glucocorticoids, diuretic and ACE inhibitor drugs 
which are systematic in mode of action which resulted in 
their action on other sites also where no such action was 
required. 
Co-morbidity related to nephrotic syndrome was also 
observed. Asthma, epilepsy, inflammatory bowel disease and 
prematurity were found in patients suffering from nephrotic 
syndrome. Methylxanthine, sedatives, aminosalicylates and 
miscellaneous drugs were prescribed for co-morbid patients.  
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